SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma gets nod to incorporate wholly owned subsidiary in Sri Lanka

22 May 2025 Evaluate

Mankind Pharma has received approval for incorporation of wholly owned subsidiary, directly or indirectly, in Sri Lanka (Foreign WOS). The Proposed Foreign WOS shall carry out the business of import, trading, promotion, marketing, distribution, contract manufacturing of Pharmaceutical & OTC products in Sri Lanka.

The Board of Directors of the Company at its meeting held on May 21, 2025, has approved the same.

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.


Mankind Pharma Share Price

2193.25 49.65 (2.32%)
21-Apr-2026 10:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.70
Dr. Reddys Lab 1222.75
Cipla 1230.90
Zydus Lifesciences 931.45
Lupin 2326.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×